Delivery Order SPE2DB22D9353-SPE2DB23FX2DE

Award Date 6/23/23
Potential Completion Date 7/17/23
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $20,712 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense. DMS will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, completing performance by September 25, 2023. No set aside designation or subcontractors were identified. The Defense...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $10,000 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the agency's medical supply needs. DMS Pharmaceutical will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, completing performance within three weeks of the April 3rd start date. No...
The Defense Logistics Agency awarded a $11,257 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DLA will receive 10 ML vials of the specified anesthetic to support DoD requirements. The single award was issued under an unspecified government-wide acquisition contract vehicle or blanket purchase agreement held by DMS. Work will be performed in Park Ridge, Illinois and must be completed by July 18, 2023. No socioeconomic designations or...
The Defense Logistics Agency, on behalf of the Department of Defense, awarded a $99,524 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an unspecified government-wide acquisition contract vehicle. DMS Pharmaceutical will deliver 20mL vials of the specified anesthetic to a facility in Park Ridge, Illinois, with performance required between August 1st and 22nd, 2023. No subcontractors or set aside designations...
The Defense Logistics Agency Troop Support Medical awarded a $565,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DMS Pharmaceutical Group will deliver 10,000 vials of the specified anesthetic to a facility in Park Ridge, Illinois, completing performance within one month from late July through mid-August 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military...
The Defense Logistics Agency awarded a delivery order valued at approximately $7,464 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. The order was issued against an existing DLA contract vehicle and has a period of performance from July 5, 2023 through July 26, 2023. As the...
The Defense Logistics Agency Troop Support Medical awarded a $565,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 133 MG/10 ML vials. DMS Pharmaceutical Group will deliver 10 mL vials of the specified anesthetic to locations in Park Ridge, Illinois under the terms of the order, which runs from July 12, 2023 to August 2, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military...
The Defense Logistics Agency, on behalf of the Department of Defense, awarded a $2,814 delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 133 MG/10 ML vials. The firm fixed price order calls for 10 mL vials of the specified anesthetic to be delivered to a location in Park Ridge, Illinois between September 7th and 28th, 2023. DMS Pharmaceutical will serve as the prime contractor on this small order in support of DLA pharmaceutical procurement programs. No subcontractors or set aside...
The Defense Logistics Agency awarded a $24,881 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. DLA will receive 20mL vials of the specified anesthetic to support Department of Defense requirements. The single order was issued under an existing DLA contract vehicle and will be fulfilled by DMS from their facility in Park Ridge, Illinois by August 8, 2023. No set aside provisions or subcontractors were identified. This order for a...
The Defense Logistics Agency awarded a $14,928.66 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to various Department of Defense components. DMS Pharmaceutical will deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a facility in Park Ridge,...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB23FX2DE
    Delivery Order

The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. DLA will receive 20mL vials of the specified anesthetic to support Department of Defense needs. The firm fixed price order was issued against an unidentified contracting vehicle and carries a period of performance from June 23rd through July 17th, 2023. DMS Pharmaceutical will fulfill the order from its facility in Park Ridge, Illinois without any subcontractor involvement or designated set-asides. This award continues DLA's longstanding role in procuring pharmaceuticals and medical supplies for military treatment facilities worldwide.

Generated 12/20/23, 3:02 PM